New variations in human OX40 ligand (CD134L) gene

Area of Science:

• Genetics
• Immunology
• Rheumatology

Background:

• The OX40 ligand (OX40L), also known as CD134L, plays a crucial role in immune responses.
• Genetic variations in immune-related genes can influence susceptibility to autoimmune diseases.
• Understanding genetic polymorphisms in OX40L may provide insights into disease mechanisms.

Purpose of the Study:

• To identify and characterize novel genetic variations within the OX40 ligand (OX40L) gene and its regulatory regions.
• To determine the frequency of identified variations in a healthy Japanese population.
• To investigate potential associations between these OX40L variations and the development of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).

Main Methods:

• Sequencing of the OX40L gene and its 5' upstream region.
• Identification and genotyping of genetic variations, including single nucleotide polymorphisms (SNPs).
• Statistical analysis to assess the association between identified variations and the presence of RA and SLE.

Main Results:

• Three new variations were identified: -921 (G-->A) in the 5' upstream region, -19 (C-->G) in the 5' untranslated region, and 202 + 25 (G-->T) in intron 2.
• The -921 (G-->A) and 202 + 25 (G-->T) variations were found in a significant proportion of healthy Japanese individuals, classifying them as common SNPs.
• No significant association was found between any of the identified OX40L variations and the presence of rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE).

Conclusions:

• Novel genetic variations in the OX40 ligand (OX40L) gene have been identified.
• Two common single nucleotide polymorphisms (SNPs) in OX40L were characterized in the Japanese population.
• These specific OX40L variations do not appear to be associated with rheumatoid arthritis or systemic lupus erythematosus.